Long-term effects of a lifestyle intervention on the health of children and teachers at cardiovascular risk in schools of disadvantaged communities in South Africa

ISRCTN ISRCTN15648510
DOI https://doi.org/10.1186/ISRCTN15648510
Secondary identifying numbers Swiss National Science Foundation (SNF) No. 320030_192651
Submission date
15/04/2020
Registration date
17/04/2020
Last edited
03/04/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The burden of non-communicable diseases (NCDs) is rapidly increasing, especially in low- and middle-income countries (LMICs), and has been recognized as one of the biggest public health challenges of our era. While physical activity plays an important part in the prevention of NCDs in adulthood, low levels have been shown in South African youths. Children in disadvantaged communities are at particular risk of compromised health and underdevelopment. Promoting healthy lifestyles through health interventions in educational settings has proven effective at reducing the risk for NCDs. Furthermore, teachers’ own health in these communities is also poor and their collaboration as role models is essential for a successful implementation of such lifestyle interventions. In this context, a concerted community-health programme called KaziBantu was designed to enhance literacy and health of both children (KaziKidz) and teachers (KaziHealth) and was implemented in schools of marginalized communities in Port Elizabeth. Preliminary results are positive regarding the intervention but also showed that some children and teachers were at risk of developing non-communicable diseases. At the same time, discontinuation of these programmes after the end of funding is high. Therefore, this study will follow-up the KaziBantu intervention in these schools to assess its sustained implementation and the achievement of health effects under real-world conditions. The first aim of this study is to first examine long-term improvement and preservation of health effects on metabolic risk factors for NCDs in at-risk children and teachers. The second aim is to evaluate long-term feasibility, acceptance, adoption, implementation, maintenance and dissemination of the both KaziKidz and KaziHealth interventions at an individual, community, organizational and institutional level in Port Elizabeth. The third aim is to explore correlations between health effects, health behaviours and adoption and implementation level.

Who can participate?
Children in 5th – 7th grades aged 9 to 14 and teachers aged 21 to 65 from the 8 schools that participated in the KaziBantu study and who were identified for having risk factors for cardiometabolic disease (e.g. obesity, high blood pressure, diabetes)

What does the study involve?
Children and teachers will be followed-up over a 2-year period, during which measurements of health status and disease history, blood tests and body composition, physical activity and nutrition will be assessed at two different time points. Teachers and parents of the children participating in the study, school principals from the eight participating schools and authorities from the Education department will be interviewed at two different time points in order to evaluate the feasibility, acceptance, implementation and maintenance of both KaziKidz and KaziHealth interventions.

What are the possible benefits and risks of participating?
Children will be assessed physically (by a professional school nurse) and clinically in terms of cardiovascular health risks and evidence of malnutrition (by qualified biokineticists) twice during the two-year period. These children would have the benefit of having their parents alerted to any red flag(s) identified during the assessment and they will be encouraged to take their child to the nearest clinic for a medical examination. They will also receive a referral letter providing details of the identified issue of concern. The child participants will also have the continued benefit of exposure to a school-based health promotion programme that their teachers were trained to implement and are hopefully successfully implementing on their own. Teachers will benefit as they will receive two free health assessments and a personalised health profile based on internationally established clinical cut-offs over the two-year period of the study. Additionally, the teachers will have the opportunity to participate in an online course on self-assessment of personal health to educate themselves on health and wellness knowledge. Furthermore, teachers presenting with severe chronic diseases (e.g., type 2 diabetes, obesity, high blood pressure) will receive a referral letter that they could present to their medical doctor, or a nearby health clinic. However, the cost of the latter consultations will be for their own account. Most measurements are non-invasive without specific risks involved. Blood lipids, haemoglobin and blood glucose levels are assessed with a finger prick blood test. The capillary blood sampling method is minimally invasive and, therefore, only involves minimal risks.

Where is the study run from?
1. University of Basel (Switzerland)
2. Nelson Mandela University (South Africa)
3. Swiss Tropical and Public Health Institute (Switzerland)

When is the study starting and how long is it expected to run for?
April 2020 to November 2021

Who is funding the study?
Swiss National Science Foundation (SNF) (Switzerland)

Who is the main contact?
Ms Patricia Arnaiz
patricia.arnaiz@unibas.ch

Study website

Contact information

Ms Patricia Arnaiz
Scientific

Department of Sport, Exercise and Health (DSBG)
University of Basel
Birsstrasse 320B
Basel
4052
Switzerland

ORCiD logoORCID ID 0000-0001-5626-3510
Phone +41 (0)61 207 47 80
Email patricia.arnaiz@unibas.ch
Prof Uwe Pühse
Scientific

Department of Sport, Exercise and Health (DSBG)
University of Basel
Birsstrasse 320B
Basel
4052
Switzerland

ORCiD logoORCID ID 0000-0003-1228-316X
Phone +41 (0)61 207 47 84
Email uwe.puehse@unibas.ch

Study information

Study designObservational longitudinal cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)School
Study typePrevention
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleSustainability of a school-based health promotion intervention in children and teachers at risk for non-communicable diseases in marginalised communities in Port Elizabeth, South Africa
Study objectivesThe study aims at following-up an established school-based health promotion intervention in order to strengthen the evidence for its effectiveness in promoting long-lasting positive lifestyle changes that ultimately seek to improve cardiovascular risk factors such as obesity, hypertension, dyslipidemia and hyperglycemia among children and teachers in selected schools of marginalised areas of Port Elizabeth, South Africa.
Ethics approval(s)1. Approved 21/07/2020, human research ethics committee (REC-H) from the Nelson Mandela University (PO Box 77000, Nelson Mandela University, Port Elizabeth, 6031, South Africa; +27 (0) 41 504 1111; info@mandela.ac.za), ref: H20-HEA-HMS-001
2. Approved 12/05/2020, Swiss ethics committee (Ethikkommission Nordwest- und Zentralschweiz, EKNZ, Hebelstrasse 53, 4056 Basel, Switzerland; +41 (0)61 268 13 50; eknz@bs.ch), ref: Req-2020-00430
3. Approved 07/12/2020, Eastern Cape Department of Education (Private Bag X0032, 5605 Bhisho, South Africa; +27 (0)40 608 4200/8; viwe.mkona@ecdoe.gov.za)
Health condition(s) or problem(s) studiedNon-communicable diseases: obesity, hypertension, diabetes, dyslipidemia
InterventionCurrent interventions as of 10/03/2021:

A cohort of identified at-risk children and at-risk teachers from 8 quintile 3 primary schools in Port Elizabeth, South Africa, will be followed-up during a 2-year period.

Assessments of health outcomes and behaviours of both children and teachers will be collected at two time points.

Community feasibility and acceptance, as well as organizational and institutional implementation and dissemination levels, will also be enquired.

A comprehensive evaluation of these parameters will follow the RE-AIM framework and its proposed dimensions – (i) Reach, (ii) Efficacy, (iii) Adoption, (iv) Implementation and (v) Maintenance.

_____

Previous interventions:

A cohort of identified at-risk children and at-risk teachers from 8 quintile 3 primary schools in Port Elizabeth, South Africa, will be followed-up during a 2-year period.

Assessments of health outcomes and behaviours of both children and teachers will be collected at two time points.

Community feasibility and acceptance, as well as organizational and institutional implementation and dissemination levels, will also be enquired at two time points.

A comprehensive evaluation of these parameters will follow the RE-AIM framework and its proposed dimensions – (i) Reach, (ii) Efficacy, (iii) Adoption, (iv) Implementation and (v) Maintenance.
Intervention typeBehavioural
Primary outcome measureCurrent primary outcome measure as of 10/03/2021:

Assessed 1 and 2 years post KaziBantu intervention:
1. Body weight, assessed using a digital weighing scale
2. Body height, assessed using a stadiometer
3. Body mass index, calculated as weight (kg)/height (m)2
4. Waist and hip circumference, assess using a tape
5. Body fat percentage, assessed using bioelectrical impedance analysis (BIA)
6. Self-reported health status, assessed by questionnaire
7. Blood pressure (systolic and diastolic), assessed using oscillometry with a digital blood pressure monitor
8. Blood lipids (TC, HDL-C, LDL-C, TG, Non-HDL, C-HDL ratio), measured using the Alere Afinion AS100 analyser
9. Blood glucose (HbA1c), measured using the Alere Afinion AS100 analyser
10. Haemoglobin concentration, assessed using the HemoCue Hb 301 system
11. Objectively measured physical activity, assessed using an ActiGraph accelerometer
12. Self-reported physical activity, assessed via the Health-Behaviour of School-Aged Children (HBSC) questionnaire
13. Self-reported diet, assessed via the 24-hour recall questionnaire
14. General health assessment, assessed for teachers via online seminar
15. Implementation status, assessed via questionnaire
16. Feasibility and acceptability, assessed via semi-structured interviews and focus group discussions

_____

Previous primary outcome measure:

Assessed 1 and 2 years post KaziBantu intervention:
1. Body weight, assessed using a digital weighing scale
2. Body height, assessed using a stadiometer
3. Body mass index, calculated as weight (kg)/height (m)2
4. Waist and hip circumference, assess using a tape
5. Body fat percentage, assessed using bioelectrical impedance analysis (BIA)
6. Physical examination, assessed face-to-face by a professional nurse
7. Self-reported health status, assessed by questionnaire
8. Blood pressure (systolic and diastolic), assessed using oscillometry with a digital blood pressure monitor
9. Blood lipids (TC, HDL-C, LDL-C, TG, Non-HDL, C-HDL ratio), measured using the Alere Afinion AS100 analyser
10. Blood glucose (HbA1c), measured using the Alere Afinion AS100 analyser
11. Haemoglobin concentration, assessed using the HemoCue Hb 301 system
12. Objectively measured physical activity, assessed using an ActiGraph accelerometer
13. Self-reported physical activity, assessed via the Health-Behaviour of School-Aged Children (HBSC) questionnaire
14. Self-reported diet, assessed via the 24-hour recall questionnaire
15. General health assessment, assessed for teachers via online seminar
16. Implementation status, assessed via semi-structured interviews
17. Feasibility and acceptability, assessed via focus group discussions once in the fall of 2021
Secondary outcome measuresThe following control variables will be assessed via questionnaire 1 and 2 years post KaziBantu intervention:
1. Age
2. Sex
3. Socioeconomic status
4. Ethnicity
5. Home language
6. School
7. Grade
Overall study start date01/04/2020
Completion date30/11/2021

Eligibility

Participant type(s)Mixed
Age groupMixed
Lower age limit10 Years
Upper age limit65 Years
SexBoth
Target number of participants300 children and 150 teachers
Total final enrolment459
Key inclusion criteriaCurrent inclusion criteria as of 17/12/2020:
1. Children and teachers from the KaziBantu study population
2. Children aged approximately 10–13 years old (4th to 7th grade)
3. Teachers aged approximately 21–65 years old
4. Children identified for being at high-risk for non-communicable diseases defined as presenting at least:
4.1. Pre- or hypertension
4.2. Pre- or diabetes
4.3. Borderline or hypercholesterolemia
4.4. Overweight or obesity
5. Written informed consent by parent/guardian for children and by teachers

Previous inclusion criteria:
1. Children and teachers from the KaziBantu study population
2. Children aged approximately 10–13 years old (4th to 7th grade)
3. Teachers aged approximately 21–65 years old
4. Children and teachers identified for being at high-risk for non-communicable diseases defined as presenting at least:
4.1. Pre- or hypertension
4.2. Pre- or diabetes
4.3. Borderline or hypercholesterolemia
4.4. Overweight or obesity
5. Written informed consent by parent/guardian for children and by teachers
Key exclusion criteria1. Participation in another clinical trial
2. Lack of written informed consent
Date of first enrolment15/02/2021
Date of final enrolment15/03/2021

Locations

Countries of recruitment

  • South Africa

Study participating centre

Nelson Mandela University
PO Box 77000
Port Elizabeth
6031
South Africa

Sponsor information

Swiss National Science Foundation
Government

Wildhainweg 3
PO Box
Bern
3001
Switzerland

Phone +41 (0)31 308 22 22
Email desk@snf.ch
Website http://www.snf.ch/en/Pages/default.aspx
ROR logo "ROR" https://ror.org/00yjd3n13

Funders

Funder type

Government

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Schweizerischer Nationalfonds, Swiss National Science Foundation, Fonds National Suisse de la Recherche Scientifique, Fondo Nazionale Svizzero per la Ricerca Scientifica, Fonds National Suisse, Fondo Nazionale Svizzero, Schweizerische Nationalfonds, SNF, SNSF, FNS
Location
Switzerland

Results and Publications

Intention to publish date30/09/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository
Publication and dissemination planStudy protocol is planned to be published in an open-access peer-reviewed journal.

Consolidation and communication of results to the scientific community and relevant authorities will be performed towards the end of the project. The results will be summarized in manuscripts, which will be submitted for publication in the peer-reviewed open-access international literature (e.g. BMC Public Health, Journal of Sports Sciences and the British Medical Journal). Results will also be presented at relevant national and international scientific meetings.
IPD sharing planCurrent individual participant data (IPD) sharing statement as of 17/11/2021:
The individual de-identified participant data generated during and/or analysed during the current study will be stored in the publically available repository https://zenodo.org. Consent from participants was obtained, by what access criteria the data will be shared including with whom, for what types of analyses, and by what mechanism. Data is composed of a range of quantitative and qualitative data including: anthropometric (body weight, height, waist and hip circumferences), clinical (blood pressure, blood lipid profile, HbA1c), physical activity (sports participations, type and amount of physical activity), diet behaviour (type and amount of food), intervention feasibility, acceptance and implementation. Data will become available 36 months after the end of the study for at least 10 years.


Previous individual participant data (IPD) sharing statement:
All participant level data will be stored in Excel and Pdf form in the publicly accessible Zenodo Data Repository (https://zenodo.org), which represents a non-profit storage and sharing solution for data compliant with the funding agency requirements (SNF FAIR Data Principles). 300 datasets will be collected at two different time points with an estimated volume of 100 GB.
All participants - or children guardians - will sign a consent form submitted to and approved by the responsible ethics committee. The consent forms will authorize future sharing and usage of the data. Anonymity of the participants is guaranteed, as the researchers will not deposit raw files in order not to compromise this guarantee. Instead, anonymized transcripts of data files will be deposited. All identifying information will be kept in a locked filing cabinet and not stored with electronic files.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 05/10/2021 21/10/2021 Yes No
Results article 12/05/2023 25/05/2023 Yes No
Other publications Qualitative descriptive study 01/04/2024 03/04/2024 Yes No

Editorial Notes

03/04/2024: Publication reference added.
25/03/2023: Publication reference added.
16/03/2023: The intention to publish date was changed from 30/03/2023 to 30/09/2023.
13/12/2022: The intention to publish date was changed from 01/12/2022 to 30/03/2023.
17/11/2021: The following changes have been made:
1. The individual participant data (IPD) sharing statement has been updated.
2. The total final enrolment number has been added.
21/10/2021: The following changes have been made:
1. Publication reference added.
2. The overall trial end date has been changed from 01/04/2023 to 30/11/2021 and the plain English summary has been updated to reflect this change.
3. The intention to publish date has been changed from 01/10/2020 to 01/12/2022.
10/03/2021: The following changes were made to the trial record:
1. The recruitment start date was changed from 01/06/2020 to 15/02/2021.
2. The recruitment end date was changed from 01/04/2021 to 15/03/2021.
3. The interventions were changed.
4. The primary outcome measures were changed.
5. The target number of participants was changed from 300 children and 100 teachers to 300 children and 150 teachers.
17/12/2020: The following changes were made to the trial record:
1. Ethics approval details added.
2. The target number of participants was changed from 'Approximately 200 children and 50 teachers' to '300 children and 100 teachers'.
27/07/2020: Due to current public health guidance, recruitment for this study has been paused. Ethics approval details added.
17/04/2020: Trial's existence confirmed by Swiss National Science Foundation.